In the context of closed-loop glycemic control, MPC has shown the skillfulness to improve glucose regulation in patients with type 1 diabetes mellitus (T1DM). To reduce its complexity, many of the proposed control strategies have been designed based on linear time-invariant (LTI) models, without accounting for intraday parametric fluctuations. In this work, a pulsatile Zone Model Predictive Control (pZMPC) is examined under a realistic patterns of intraday insulin sensitivity ( SI ), according to the recent updates of the FDA-approved UVA/Padova simulator. Nominal updates of the postprandial insulin sensitivity are explicitly taken into account in the control-oriented model to improve the glucose predictions. The resulting controller is tested ‘in-silico’ with the FDA-approved UVA/Padova simulator, while its behavior is analyzed by comparing the usual statistical metrics with the corresponding time-invariant configuration. As expected, results show significant improvements, which justifies the (reasonable) increment in the controller complexity.

(2022). MPC-based artificial pancreas accounting for circadian variability of insulin sensitivity . Retrieved from https://hdl.handle.net/10446/234983

MPC-based artificial pancreas accounting for circadian variability of insulin sensitivity

Ferramosca, Antonio;
2022-01-01

Abstract

In the context of closed-loop glycemic control, MPC has shown the skillfulness to improve glucose regulation in patients with type 1 diabetes mellitus (T1DM). To reduce its complexity, many of the proposed control strategies have been designed based on linear time-invariant (LTI) models, without accounting for intraday parametric fluctuations. In this work, a pulsatile Zone Model Predictive Control (pZMPC) is examined under a realistic patterns of intraday insulin sensitivity ( SI ), according to the recent updates of the FDA-approved UVA/Padova simulator. Nominal updates of the postprandial insulin sensitivity are explicitly taken into account in the control-oriented model to improve the glucose predictions. The resulting controller is tested ‘in-silico’ with the FDA-approved UVA/Padova simulator, while its behavior is analyzed by comparing the usual statistical metrics with the corresponding time-invariant configuration. As expected, results show significant improvements, which justifies the (reasonable) increment in the controller complexity.
2022
Abuin, Pablo; Ferramosca, Antonio; Gonzalez, Alejandro H.
File allegato/i alla scheda:
File Dimensione del file Formato  
MPC-based_artificial_pancreas_accounting_for_circadian_variability_of_insulin_sensitivity.pdf

Solo gestori di archivio

Versione: publisher's version - versione editoriale
Licenza: Licenza default Aisberg
Dimensione del file 1.67 MB
Formato Adobe PDF
1.67 MB Adobe PDF   Visualizza/Apri
Pubblicazioni consigliate

Aisberg ©2008 Servizi bibliotecari, Università degli studi di Bergamo | Terms of use/Condizioni di utilizzo

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10446/234983
Citazioni
  • Scopus 0
  • ???jsp.display-item.citation.isi??? 0
social impact